RA
LVGO

Rovida Advisors’s Livongo Health, Inc. Common Stock LVGO Stock Holding History

Rovida Advisors’s Portfolio LVGO Stock Details LVGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-250,671
Closed -$6.27M – 58
2019
Q4 		$6.27M Buy
+250,671
New +$5.99M 0.33% 41

Other funds holding LVGO

KXA
KPCB XVI Associates Menlo Park, California $225M AUM 26.26% 1-Year Est. Return
DIG
Dragoneer Investment Group San Francisco, California $3B AUM 6.95% 1-Year Est. Return
SV
Sapphire Ventures Austin, Texas $99.4M AUM 23.75% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Rovida Advisors's LVGO Position: Q1 2020 in Review

Rovida Advisors sold out of Livongo Health, Inc. Common Stock (LVGO) in Q1 2020, closing a stake of 250,671 shares — an estimated $6.27M sold.

Rovida Advisors first reported a position in LVGO in Q4 2019 and held it in 1 quarter. The position peaked at $6.27M in Q4 2019. 145 funds tracked by Wall St. Rank hold LVGO as of Q1 2020.

  • Rovida Advisors reported no remaining Livongo Health, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
  • Rovida Advisors sold 250,671 Livongo Health, Inc. Common Stock shares in Q1 2020, an estimated $6.27M.
  • Rovida Advisors first reported a position in Livongo Health, Inc. Common Stock in Q4 2019 and held it in 1 quarter.
  • Rovida Advisors's Livongo Health, Inc. Common Stock position peaked at $6.27M in Q4 2019.
  • 145 funds tracked by Wall St. Rank held Livongo Health, Inc. Common Stock as of Q1 2020.

Based on Rovida Advisors's 13F filing for Q1 2020, filed 13 May 2020.